Researchers from Ohio State University Comprehensive Cancer Center, the University of Alberta, and elsewhere explore the broader mutation patterns found in acute myeloid leukemia (AML) tumors marked by recurrent balanced chromosome 11 rearrangements involving the KMT2A gene.